279 related articles for article (PubMed ID: 32839217)
1. Adjuvant β-Lactam Therapy Combined with Vancomycin or Daptomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia: a Systematic Review and Meta-analysis.
Wang C; Ye C; Liao L; Wang Z; Hu Y; Deng C; Liu L
Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32839217
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant
Yi YH; Wang JL; Yin WJ; Xu WH
Microb Drug Resist; 2021 Aug; 27(8):1044-1056. PubMed ID: 33728980
[No Abstract] [Full Text] [Related]
3. Combination of Vancomycin or Daptomycin and Beta-lactam Antibiotics: A Meta-analysis.
Kale-Pradhan PB; Giuliano C; Jongekrijg A; Rybak MJ
Pharmacotherapy; 2020 Jul; 40(7):648-658. PubMed ID: 32533859
[TBL] [Abstract][Full Text] [Related]
4. Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study.
Jorgensen SCJ; Zasowski EJ; Trinh TD; Lagnf AM; Bhatia S; Sabagha N; Abdul-Mutakabbir JC; Alosaimy S; Mynatt RP; Davis SL; Rybak MJ
Clin Infect Dis; 2020 Jun; 71(1):1-10. PubMed ID: 31404468
[TBL] [Abstract][Full Text] [Related]
5. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
Tong SYC; Lye DC; Yahav D; Sud A; Robinson JO; Nelson J; Archuleta S; Roberts MA; Cass A; Paterson DL; Foo H; Paul M; Guy SD; Tramontana AR; Walls GB; McBride S; Bak N; Ghosh N; Rogers BA; Ralph AP; Davies J; Ferguson PE; Dotel R; McKew GL; Gray TJ; Holmes NE; Smith S; Warner MS; Kalimuddin S; Young BE; Runnegar N; Andresen DN; Anagnostou NA; Johnson SA; Chatfield MD; Cheng AC; Fowler VG; Howden BP; Meagher N; Price DJ; van Hal SJ; O'Sullivan MVN; Davis JS;
JAMA; 2020 Feb; 323(6):527-537. PubMed ID: 32044943
[TBL] [Abstract][Full Text] [Related]
6. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.
Murray KP; Zhao JJ; Davis SL; Kullar R; Kaye KS; Lephart P; Rybak MJ
Clin Infect Dis; 2013 Jun; 56(11):1562-9. PubMed ID: 23449272
[TBL] [Abstract][Full Text] [Related]
7. Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.
Casapao AM; Jacobs DM; Bowers DR; Beyda ND; Dilworth TJ;
Pharmacotherapy; 2017 Nov; 37(11):1347-1356. PubMed ID: 28949410
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant
Dilworth TJ; Casapao AM; Ibrahim OM; Jacobs DM; Bowers DR; Beyda ND; Mercier RC
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617094
[TBL] [Abstract][Full Text] [Related]
9. What do beta-lactams add to vancomycin or daptomycin in the treatment of patients with methicillin-resistant
García Aragonés L; Blanch Sancho JJ; Segura Luque JC; Mateos Rodriguez F; Martínez Alfaro E; Solís García Del Pozo J
Postgrad Med J; 2022 Jan; 98(1155):48-56. PubMed ID: 33563707
[TBL] [Abstract][Full Text] [Related]
10. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
[TBL] [Abstract][Full Text] [Related]
11. Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care.
Johnson TM; Molina KC; Miller MA; Kiser TH; Huang M; Mueller SW
Int J Antimicrob Agents; 2021 Apr; 57(4):106310. PubMed ID: 33609718
[TBL] [Abstract][Full Text] [Related]
12. Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
Geriak M; Haddad F; Rizvi K; Rose W; Kullar R; LaPlante K; Yu M; Vasina L; Ouellette K; Zervos M; Nizet V; Sakoulas G
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858203
[TBL] [Abstract][Full Text] [Related]
13. The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.
McConeghy KW; Bleasdale SC; Rodvold KA
Clin Infect Dis; 2013 Dec; 57(12):1760-5. PubMed ID: 23985343
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacoeconomic analysis of the treatment of methicillin-resistant Staphylococcus aureus with daptomycin or vancomycin].
Rubio-Terrés C; Rubio-Rodríguez D; Majos N; Grau S
Rev Esp Quimioter; 2012 Dec; 25(4):283-92. PubMed ID: 23303261
[TBL] [Abstract][Full Text] [Related]
15. Duration of prior vancomycin therapy and subsequent daptomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia.
Culshaw D; Lamp KC; Yoon MJ; Lodise TP
Diagn Microbiol Infect Dis; 2015 Oct; 83(2):193-7. PubMed ID: 26184127
[TBL] [Abstract][Full Text] [Related]
16. Pre-clinical Impact of the Synergistic Mechanism of Daptomycin and Ceftaroline on Patients with Methicillin-resistant Staphylococcus aureus Bacteremia Infections.
Eliazar J; Johnson T; Chbib C
Curr Rev Clin Exp Pharmacol; 2021; 16(4):296-299. PubMed ID: 33423652
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Vancomycin plus a β-Lactam versus Vancomycin Only for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
Truong J; Veillette JJ; Forland SC
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133561
[TBL] [Abstract][Full Text] [Related]
18. In MRSA bacteremia, adding a β-lactam to usual care did not improve a composite outcome at 90 days.
Atalla E; Mylonakis E
Ann Intern Med; 2020 Jun; 172(12):JC67. PubMed ID: 32539506
[TBL] [Abstract][Full Text] [Related]
19. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.
Holubar M; Meng L; Alegria W; Deresinski S
Infect Dis Clin North Am; 2020 Dec; 34(4):849-861. PubMed ID: 33011050
[TBL] [Abstract][Full Text] [Related]
20. Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections.
Agnello S; Wardlow LC; Reed E; Smith JM; Coe K; Day SR
Int J Antimicrob Agents; 2021 Aug; 58(2):106363. PubMed ID: 34033912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
